Skip to main content
Clinical Trials/NCT01256099
NCT01256099
Completed
Not Applicable

Guided Internet-treatment for Insomnia. Treatment Effects, Health Economics and Interaction With Depression

Karolinska Institutet1 site in 1 country191 target enrollmentJanuary 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insomnia
Sponsor
Karolinska Institutet
Enrollment
191
Locations
1
Primary Endpoint
MADRS-S
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

This study includes two sub-trials.

In trial 1 patients suffering from insomnia but not meeting the criteria for depression are randomised to either therapist guided Internet-based CBT for insomnia or to a control group with a non-guided, brief self-help program that acts as a placebo control. The primary purpose is to evaluate reduction in Insomnia severity (compared to placebo) after treatment and at follow-ups at 6-month, 1 year and 3 years. Secondary purpose is to evaluate the costeffectiveness of the treatment and to evaluate if the insomnia treatment has a preventive effect on future depressive episodes. Recruitment is done through mass media and includes all regions of Sweden. Initial assessment based on questionnaires and telephone interviews.

Trial 2 includes patients suffering from both Insomnia and depression. Randomization is done between either CBT for insomnia or CBT for depression (both Internet-based) to evaluate each respective treatment's effect on both insomnia and depression. The patients need for further treatment after the initial one will be measured and used as a secondary outcome. Recruitment is done through mass media but only citizens in the Stockholm area are included since the initial assessment are based on both questionnaires and telephone interviews as well as a visit at a psychiatrist located at the Internet psychiatry clinic in Stockholm.

Both trials will include health economic data and analysis. For the longer follow-up periods (1 and 3 years), registers will be used to analyse consumption of sleep medication and antidepressants as well as general health care utilization.

Registry
clinicaltrials.gov
Start Date
January 2010
End Date
February 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Viktor Kaldo

Principal Investigator

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • Clinical level of Insomnia (more than 10 on ISI)
  • Meets criteria for Insomnia according to DSM-IV-TR
  • Enough language skills
  • Only Trial 2: Meets criteria for Major Depressive Disorder according to DSM-IV-TR

Exclusion Criteria

  • Sleep disorders requiring other treatment
  • High consumption of alcohol/drugs that affect sleep
  • Started to use or changed the dose of antidepressant drug during the last 2 months
  • Somatic or psychiatric conditions requiring acute care
  • Working night shifts
  • Only Trial 1: Meets criteria for Major Depressive Disorder according to DSM-IV-TR

Outcomes

Primary Outcomes

MADRS-S

Time Frame: 3-years follow-up

ISI

Time Frame: 3-years follow-up

Insomnia Severity Index (ISI)

Time Frame: Post-treatment (9 weeks)

7-item, self-rated questionnaire measuring insomnia severity. Bastien, C. H., Vallières, A., \& Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2, 297-307.

Secondary Outcomes

  • Sleep Diary(Same as primary outcomes)
  • Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P)(Same as Primary outcomes)
  • EQ-5D(Same as primary outcomes)

Study Sites (1)

Loading locations...

Similar Trials